Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | TYR | P14679 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.43 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | TACR2 | P21452 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL560620 | 1.00 | ALOX5 (0.52) | ALOX5CYP3A4TYRTP53MEN1 | |
| SCHEMBL23880370 | 0.98 | ALOX5 (0.48) | ALOX5CYP3A4TYRTP53MEN1 | |
| SCHEMBL12925073 | 0.91 | ALOX5 (0.47) | ALOX5CYP3A4TYRTP53MEN1 | |
| SCHEMBL725139 | 0.91 | ALOX5 (0.47) | ALOX5CYP3A4TYRTP53MEN1 | |
| SCHEMBL17767410 | 0.88 | ALOX5 (0.43) | ALOX5CYP3A4TYRTP53MEN1 | |
| SCHEMBL21286971 | 0.86 | TYR (0.45) | ALOX5CYP3A4TYRTP53MEN1 | |
| SCHEMBL11983254 | 0.84 | THRA (0.42) | ALOX5CYP3A4TYRTP53MEN1 | |
| SCHEMBL3657714 | 0.81 | ALOX5 (0.44) | ALOX5CYP3A4TYRTP53MEN1 | |
| SCHEMBL5684607 | 0.81 | TYR (0.53) | ALOX5CYP3A4TYRTP53MEN1 | |
| SCHEMBL28209900 | 0.80 | ESR1 (0.53) | ALOX5CYP3A4TYRTP53MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112250629-B | Surfactant type corrosion inhibitor and preparation method thereof | 山东滨州昱诚化工科技有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-112250629-A | Surfactant type corrosion inhibitor and preparation method thereof | 张玉花 | 2021-01-22 | — | — | CN | claimed |
| US-12485407-B2 | Catalyst for hydrogenation reaction and method for producing same | LG CHEM, LTD (KR) | 2025-12-02 | — | — | US | disclosed |
| EP-3903934-B1 | USE OF A CATALYST IN THE HYDROGENATION OF ALKYNE TO ALKENE | LG CHEMICAL LTD (KR) | 2025-02-12 | — | — | EP | disclosed |
| US-20240299919-A1 | CATALYST FOR HYDROGENATION REACTION AND METHOD FOR PRODUCING SAME | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-09-12 | — | — | US | disclosed |
| US-20220134323-A1 | CATALYST FOR HYDROGENATION REACTION AND METHOD FOR PRODUCING SAME | LG CHEM, LTD. (KR) | 2022-05-05 | — | — | US | disclosed |
| CN-112250629-B | Surfactant type corrosion inhibitor and preparation method thereof | 山东滨州昱诚化工科技有限公司 | 2022-03-25 | — | — | CN | disclosed |
| EP-3903934-A1 | CATALYST FOR HYDROGENATION REACTION AND METHOD FOR PRODUCING SAME | LG Chem, Ltd. (KR) | 2021-11-03 | — | — | EP | disclosed |
| CN-113518663-A | Catalyst for hydrogenation reaction and method for producing the same | 株式会社LG化学 | 2021-10-19 | — | — | CN | disclosed |
| WO-2021066298-A1 | CATALYST FOR HYDROGENATION REACTION AND METHOD FOR PRODUCING SAME | 주식회사 엘지화학 | 2021-04-08 | — | — | WO | disclosed |
| CN-112250629-A | Surfactant type corrosion inhibitor and preparation method thereof | 张玉花 | 2021-01-22 | — | — | CN | disclosed |
| US-9156938-B2 | Compositions, methods, and systems comprising fluorous-soluble polymers | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-10-13 | — | — | US | disclosed |
| US-9156938-B2 | Compositions, methods, and systems comprising fluorous-soluble polymers | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-10-13 | — | — | US | disclosed |
| US-8562867-B2 | Organic species that facilitate charge transfer to or from nanostructures | NANOSYS, INC. (US) | 2013-10-22 | — | — | US | disclosed |
| US-20120177578-A1 | COMPOSITIONS, METHODS, AND SYSTEMS COMPRISING FLUOROUS-SOLUBLE POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-07-12 | — | — | US | disclosed |
| US-20120177578-A1 | COMPOSITIONS, METHODS, AND SYSTEMS COMPRISING FLUOROUS-SOLUBLE POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-07-12 | — | — | US | disclosed |
| WO-2012024592-A2 | COMPOSITIONS, METHODS, AND SYSTEMS COMPRISING FLUOROUS-SOLUBLE POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220134323-A1 | CATALYST FOR HYDROGENATION REACTION AND METHOD FOR PRODUCING SAME | GRHPR, HAO2, RAD51 | ALOX5 2315/4885CYP3A4 597/4885TYR 2150/4885 |
| US-12485407-B2 | Catalyst for hydrogenation reaction and method for producing same | GRHPR, HAO2, RAD51 | ALOX5 2315/4885CYP3A4 597/4885TYR 2150/4885 |
| US-20240299919-A1 | CATALYST FOR HYDROGENATION REACTION AND METHOD FOR PRODUCING SAME | GRHPR, HAO2, RAD51 | ALOX5 2315/4885CYP3A4 597/4885TYR 2150/4885 |
| US-20120177578-A1 | COMPOSITIONS, METHODS, AND SYSTEMS COMPRISING FLUOROUS-SOLUBLE POLYMERS | NAF1, PFAS, MALT1 | ALOX5 907/4885CYP3A4 2315/4885TYR 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.